Hanni Mäntynen
About Hanni Mäntynen
Hanni Mäntynen is the Territory Manager S-ICD Finland at Boston Scientific, with a career spanning various roles in the medical and pharmaceutical industries.
Current Role at Boston Scientific
Hanni Mäntynen serves as the Territory Manager S-ICD Finland at Boston Scientific. She has held this position since 2016 and operates out of Marlborough, Massachusetts, United States. Her role likely involves overseeing the sales and distribution of subcutaneous implantable cardioverter defibrillators (S-ICDs) across her territory in Finland.
Previous Experience at Boston Scientific
Before her current role, Hanni Mäntynen was a Field Clinical Specialist CRM at Boston Scientific from 2014 to 2016. During her tenure, she supported the Cardiac Rhythm Management (CRM) division, providing insights into clinical data and helping to ensure the efficacy and safety of CRM products.
Professional Experience at Servier
From 2012 to 2014, Hanni Mäntynen worked at Servier as a representative (Lääke-edustaja). Based in Suresnes, Ile-de-France, France, her responsibilities likely included promoting and selling pharmaceutical products to healthcare professionals, ensuring the alignment of product information with medical standards.
Roles at Boehringer Ingelheim and AstraZeneca
Hanni Mäntynen's experience includes serving as a Territory Manager at Boehringer Ingelheim from 2011 to 2012 in Ingelheim, Rheinland-Pfalz, Germany. She worked at AstraZeneca as a Medical Representative from 2009 to 2010. These roles likely involved promoting medications and therapies, educating healthcare providers, and contributing to market strategies.
Early Career and Nursing Experience
Early in her career, Hanni Mäntynen worked as a Nurse and Public Health Nurse for Raision Kaupunki from 2006 to 2008. This two-year tenure included responsibilities typical of nursing roles, such as patient care and public health initiatives.
Education at Turku University of Applied Sciences
Hanni Mäntynen studied at Turku University of Applied Sciences from 2002 to 2006. The four-year program likely provided her with a strong foundation in healthcare, supporting her subsequent roles in nursing and various pharmaceutical positions.